Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (521-530 of 532) with videos related to

Pageof 54
Sort By:
Elife|April 10, 2014
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cellsDorothy K Sojka, Beatrice Plougastel-Douglas, Liping Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptorsR J Knapp, G Santoro, I A De Leon, et al.
Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.
Organic & Biomolecular Chemistry|April 5, 2007
Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonistsKejun Cheng, In Jong Kim, Mei-Jing Lee, et al.
The Journal of Experimental Medicine|June 10, 2010
The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesisPing Lu, Isaiah L Hankel, Judit Knisz, et al.
Journal of Medicinal Chemistry|July 13, 2007
Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan seriesAnne-Cécile Hiebel, Yong Sok Lee, Edward Bilsky, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 18, 2014
Creating a high-reliability health care system: improving performance on core processes of care at Johns Hopkins MedicinePeter J Pronovost, C Michael Armstrong, Renee Demski, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 6, 1997
A multicenter clinical trial of Gadolite Oral Suspension as a contrast agent for MRID L Rubin, K L Falk, M J Sperling, et al.
Pageof 54

Showing results (521-530 of 532) with videos related to

Sort By:
Pageof 54
Elife|April 10, 2014
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cellsDorothy K Sojka, Beatrice Plougastel-Douglas, Liping Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptorsR J Knapp, G Santoro, I A De Leon, et al.
Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.
Organic & Biomolecular Chemistry|April 5, 2007
Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonistsKejun Cheng, In Jong Kim, Mei-Jing Lee, et al.
The Journal of Experimental Medicine|June 10, 2010
The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesisPing Lu, Isaiah L Hankel, Judit Knisz, et al.
Journal of Medicinal Chemistry|July 13, 2007
Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan seriesAnne-Cécile Hiebel, Yong Sok Lee, Edward Bilsky, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 18, 2014
Creating a high-reliability health care system: improving performance on core processes of care at Johns Hopkins MedicinePeter J Pronovost, C Michael Armstrong, Renee Demski, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 6, 1997
A multicenter clinical trial of Gadolite Oral Suspension as a contrast agent for MRID L Rubin, K L Falk, M J Sperling, et al.
Pageof 54